XOMA Royalty Corp. (XOMA)
27.04
+1.72
(+6.79%)
USD |
NASDAQ |
Feb 24, 16:00
26.84
-0.20
(-0.74%)
After-Hours: 20:00
XOMA Royalty Research and Development Expense (Quarterly) : 0.069M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 42.90M |
| Recursion Pharmaceuticals, Inc. | 107.66M |
| Rezolute, Inc. | 14.35M |
| DiaMedica Therapeutics, Inc. | 6.437M |
| Gossamer Bio, Inc. | 45.54M |